Johns Hopkins and Pitt-linked digital pathology platform Proscia has increased its funding total to $35m with a series B round involving Hitachi Ventures.

Proscia, a US-based digital pathology technology spinout of Johns Hopkins University and University of Pittsburgh, has attracted $23m in a series B round led by Scale Venture Partners.
Hitachi Ventures, the corporate venturing arm of electronics manufacturer Hitachi, took part in the series B round.
Founded in 2014, Proscia has built a modular digital pathology platform that facilitates artificial intelligence-driven image analysis to help diagnose disease based on tissue samples.
The company’s first tool, DermAI, examines skin…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?